8-K: Danimer Scientific Establishes Executive Severance and Retention Plan

Danimer Scientific has implemented a new Executive Severance and Retention Plan, providing severance benefits to eligible executives upon certain terminations of employment.

Summary

• Danimer Scientific has adopted a new Executive Severance and Retention Plan, effective May 9, 2024.
• The plan provides severance compensation and benefits to members of the company's Senior Leadership Team and other designated executives, excluding the CEO and CFO who have separate agreements.
• The plan replaces individual employment agreements for certain executives that expired on December 31, 2023, and aims to provide consistent benefits.
• Eligible executives who are involuntarily terminated without cause or resign for good reason will receive 12 months of base salary continuation and continued health benefits at the active employee rate.
• In the event of a change in control, eligible executives will receive 24 months of base salary continuation and continued health benefits at the active employee rate if terminated within 3 months prior to or 12 months following the change in control.
• Severance payments are contingent upon the executive signing a release of claims against the company.
• The plan includes provisions to reduce severance benefits if they would trigger excise taxes under Code Sections 280G or 4960.
• The plan is intended to comply with or be exempt from Code Section 409A.

Sentiment

Score: 7

Explanation: The document is a standard corporate filing detailing a new executive severance plan. It is generally positive as it provides clarity and security for executives, but it also includes standard clauses that could be seen as negative from an executive's perspective, such as the release of claims and clawback provisions.

Positives

• The plan provides clear and consistent severance benefits for eligible executives.
• The plan ensures that executives receive continued health benefits at the same rate as active employees.
• The plan includes enhanced severance benefits in the event of a change in control, providing additional security for executives.
• The plan replaces expired individual agreements, streamlining the process and ensuring consistency.
• The plan is designed to comply with relevant tax regulations, minimizing potential tax liabilities for executives.

Negatives

• Severance payments are contingent on signing a release of claims, which may limit an executive's ability to pursue legal action against the company.
• The plan includes a clawback provision, which could result in the recovery of payments under certain circumstances.
• The plan does not include the CEO and CFO, who have separate agreements, potentially creating inconsistencies in executive compensation.

Risks

• The clawback provision could create uncertainty for executives regarding the final amount of severance payments.
• The requirement to sign a release of claims could limit an executive's legal options.
• The plan's complexity could lead to disputes over eligibility and benefit calculations.
• The plan's effectiveness in retaining executives will depend on its perceived value and competitiveness.

Future Outlook

The plan is intended to provide consistent benefits to eligible executives and assist in retaining senior-level talent. It also provides clarity on severance terms in the event of a change in control.

Management Comments

• The S&R Plan is intended, in part, to replace individual employment agreements for certain Eligible Executives whose employment agreements expired as of December 31, 2023 and to provide consistent benefits to all Eligible Executives.
• The S&R Plan was approved by the Compensation Committee of the Company's Board of Directors.

Industry Context

The implementation of a formal severance and retention plan is a common practice among publicly traded companies to attract and retain key executives. This plan aligns Danimer Scientific with industry standards for executive compensation and benefits.

Comparison to Industry Standards

• Many public companies have similar severance plans for their executives, often including base salary continuation and health benefits.
• The length of severance benefits, such as 12 months for standard terminations and 24 months for change in control, is generally consistent with industry norms.
• The inclusion of COBRA premium payments is a standard practice in executive severance packages.
• The requirement for a release of claims is also a common feature in such plans.
• Companies like Eastman Chemical, Novozymes, and BASF, which are in related industries, also have similar executive compensation and severance practices.

Stakeholder Impact

• Shareholders may view the plan as a positive step in retaining key talent.
• Eligible executives will benefit from the security of severance benefits.
• Employees may see the plan as a sign of the company's commitment to its leadership team.

Next Steps

• Eligible executives must sign a Participation Agreement to participate in the plan.
• The company will administer the plan and may delegate administration to a committee.
• The company may adopt a clawback policy in the future.

Key Dates

Keywords

severance, retention, executive compensation, change in control, COBRA, employment agreement, clawback, Code Section 409A, senior leadership team